SynthesisThe oncologist2015

The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.

Yoshikazu Hasegawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.